Autopsy report · NCT00646282
Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients
Cause of deathStaffing, sites or logistics, also slow enrollment
“slow enrollment and discontinued once original principal investigator left Emory”
Life of this trial
- Ran for about 1 year 9 months before it stopped.
- 12 participants enrolled.
- Results were posted on the registry 5 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Emory University
- Sponsor type
- University, hospital or other
- Conditions
- Hyperparathyroidism, Secondary
- Interventions
- doxercalciferol
- Participants
- 12
- Sites
- 1
- Countries
- United States
Trials that died the same way
- FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity
“prior to participant recruitment, PI left Emory, study stopped” - FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
“The principal investigator terminated the study due to inactivity and low enrollment” - Impact of Keeping a Personal Recovery Diary on Upper Extremity Disability
“The Principal Investigator left the institution so the study was stopped before completing enrollment.” - Airway Pressure Release Ventilation as a Preventative Strategy
“Principal Investigator left the institution before subjects were enrolled” - LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
“Study was discontinued due to slow enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.